Anaptysbio (ANAB) EBT Margin Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | 434,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 434,562.00 |
| Dec 31, 2025 | 52,062.00 |
| Sep 30, 2025 | 293,966.00 |
| Jun 30, 2025 | 402,740.00 |
| Mar 31, 2025 | 567,050.00 |
| Dec 31, 2024 | 309,058.00 |
| Sep 30, 2024 | -5,058.00 |
| Jun 30, 2024 | -29,420.00 |
| Mar 31, 2024 | -25,830.00 |
| Dec 31, 2023 | -52,439.00 |
| Mar 31, 2023 | -438,716.00 |
| Dec 31, 2022 | 22,181.00 |
| Jun 30, 2022 | -372,030.00 |
| Sep 30, 2021 | 15,073.00 |
| Dec 31, 2020 | 25,411.00 |
| Dec 31, 2019 | -36,037.00 |
| Jun 30, 2019 | -53,662.00 |